Cath Lab

The catheterization lab channel includes content related to interventional technologies for coronary and peripheral artery disease (PAD). Other cath lab transcatheter device technologies covered on this page included percutaneous treatment for stroke, venous interventions, heart valves, hypertension, heart failure and percutenous coronary interventions (PCI).

STOPDAPT-3 trial presented in a Hot Line Session Saturday at ESC Congress 2023
News | Antiplatelet and Anticoagulation Therapies
Dual-antiplatelet Therapy Should Remain Standard Strategy After Stent Implantation

August 28, 2023 — Prasugrel monotherapy after percutaneous coronary intervention (PCI) with drug-eluting stents is not ...

Home August 28, 2023
Home
Heart attack patients who do not take daily aspirin have an elevated likelihood of recurrent myocardial infarction, stroke or death compared with those who consistently take the drug, according to research presented at ESC Congress 2023
News | ESC
Heart Attack Patients Should Take Aspirin to Avoid a New Heart Attack, Stroke and Death

August 22, 2023 — Heart attack patients who do not take daily aspirin have an elevated likelihood of recurrent myocardia ...

Home August 22, 2023
Home
CVi screenshot
Blog | Contrast Media Injectors
BLOG: Enhancing Efficiency and Patient Care with a Modern Injector

Adjustable parameters on the ACIST® CVI® Contrast Delivery System include, flow rate, volume, pressure limit, rise time ...

Home August 22, 2023
Home
The Society for Cardiovascular Angiography & Interventions (SCAI) has released a position statement on Renal Denervation (RDN), emphasizing patient selection, optimal techniques, competence, training, and institutional recommendations
News | Renal Denervation
New SCAI Position Statement Highlights the Role of Renal Denervation in Hypertension Treatment

August 21, 2023 — The Society for Cardiovascular Angiography & Interventions (SCAI) has released a position statement on ...

Home August 21, 2023
Home
As medical advancements continue to push the boundaries of what is possible in the field of structural heart interventions, the importance of enterprise imaging has become increasingly evident.
Blog | Enterprise Imaging
BLOG: The Power of Enterprise Imaging in Structural Heart Procedures

As medical advancements continue to push the boundaries of what is possible in the field of structural heart ...

Home August 10, 2023
Home
First-of-its-kind expandable cryoballoon catheter advances cryoablation therapy, addresses key limitations with traditional systems
News | Ablation Systems
Boston Scientific Receives FDA Approval for the POLARx Cryoablation System

August 9, 2023 — Boston Scientific Corporation announced it has received U.S. Food and Drug Administration (FDA) ...

Home August 09, 2023
Home
The 510(k) application covers Evie Ring’s pulse oximeter that includes heart rate and SpO2 data, and is expected to make it one of the first consumer wearables that is also cleared for clinical use
News | Wearables
Biosense Webster Receives FDA Approval for Multiple Atrial Fibrillation Ablation Products to be Used in a Workflow Without Fluoroscopy

August 7, 2023 — Biosense Webster, Inc., a global leader in cardiac arrhythmia treatment and part of Johnson & Johnson M ...

Home August 07, 2023
Home
Merit’s WAVE study is a prospective, randomized, controlled, multicenter study
News | Cardiovascular Clinical Studies
Merit Medical’s WRAPSODY Arteriovenous Access Efficacy (WAVE) Pivotal Study Completes Enrollment

August 3, 2023 — Merit Medical Systems, a leading global manufacturer and marketer of healthcare technology, today ...

Home August 03, 2023
Home
the U.S Food and Drug Administration (FDA) has cleared the QuikClot Control+ Hemostatic Device to include mild and moderate bleeding in cardiac surgical procedures and bone surface bleeding following a sternotomy
News | Cath Lab
Teleflex Receives FDA Clearance for Expanded Indication for QuikClot Control+ Hemostatic Device Usage in Cardiac Surgical Procedures

August 2, 2023 — Teleflex Incorporated, a leading global provider of medical technologies, announced the U.S Food and ...

Home August 02, 2023
Home
Real-world evidence demonstrates the clinical, health equity and patient benefits of AI-powered care coordination
News | Artificial Intelligence
Three New Clinical Studies Presented at the Society of Neurointerventional Surgery Annual Meeting Further Validate Impact of Viz Neuro Suite

August 1, 2023 — Viz.ai, a leader in AI-powered disease detection and intelligent care coordination, announced the ...

Home August 01, 2023
Home
Here is a look at what DAIC viewers were reading during the month of July
Feature | Cardiovascular Business | By Melinda Taschetta-Millane
What Viewers Were Reading in July

Here is a look at what DAIC viewers were reading during the month of July:


1. Lessons Learned from World’s First ...

Home August 01, 2023
Home
Primary endpoints across three studies underscore the importance of accuracy, utility, and efficiency in coronary artery disease diagnostics and clinical decision making
News | Cardiovascular Clinical Studies
HeartFlow to Announce New Data at SCCT23

July 28, 2023 — Respective results from the REVEALPLAQUE, DECODE, and SMART-CT clinical studies demonstrate the accuracy ...

Home July 28, 2023
Home
Abiomed is recalling the Impella Intravascular Left Sided Blood Pumps because the pump’s Instructions for Use (IFU) do not adequately address precautions to take when treating patients who have undergone transcatheter aortic valve replacement (TAVR)
News | Stents
Abiomed Recalls All Impella Left Sided Blood Pumps for Risk of Motor Damage After Contact with Transcatheter Aortic Valve Replacement (TAVR) Stent

July 27, 2023 — Abiomed is recalling the Impella Intravascular Left Sided Blood Pumps because the pump’s Instructions ...

Home July 27, 2023
Home
Abbott is recalling the Amplatzer Steerable Delivery Sheath due to an increased risk for air emboli to be introduced into patients who have procedures with this device.
News | Left Atrial Appendage (LAA) Occluders
Abbott Recalls Amplatzer Steerable Delivery Sheath for Increased Risk of Air Embolism

July 26, 2023 — Abbott is recalling the Amplatzer Steerable Delivery Sheath due to an increased risk for air emboli to ...

Home July 26, 2023
Home
Under the agreement, BIS will initiate the US commercialization activities for ŌNŌCOR’s ŌNŌ Retrieval Device.
News | Cardiovascular Business
ŌNŌCOR signs an exclusive US distribution agreement with B. Braun Interventional Systems

July 26, 2023 —ŌNŌCOR LLC, a medical technology company dedicated to developing essential safety tools and other ...

Home July 26, 2023
Home
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now